Visceral leishmaniasis (VL), a deadly parasitic disease, is a major public health concern
globally. Countries affected by VL have signed the London Declaration on Neglected …

Parasites often cause devastating diseases and represent a significant public health and
economic burden. More accurate and convenient diagnostic tools are needed in support of …

Diagnostic parameters for visceral leishmaniasis (VL), a potentially fatal parasitic disease
caused by Leishmania donovani, have been redefined in the last decade with the …

Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a vector-borne
systemic disease, with a worldwide distribution causing high morbidity and mortality in the …

Tuberculosis kills over 1· 7 million people worldwide every year and nearly 40% of patients
with active tuberculosis remain undiagnosed because of the poor sensitivity of the current …

Human visceral leishmaniasis (VL), a potentially fatal disease, is most prevalent in the
Indian subcontinent, East Africa and South America. Definite diagnosis and effective …

Leishmaniasis is one of the most common vector-borne parasitic diseases in Iran.
Leishmania species identification is necessary for epidemiological aspects, precise …

Leishmania donovani (a causative agent of visceral leishmaniasis) poses a serious health
threat to the human population which is fatal if left untreated. The life cycle of Leishmania …

Human visceral leishmaniasis (VL) continues to be a life-threatening neglected tropical
disease, with close to 200 million people at risk of infection globally. Epidemics and …

Leishmaniasis is endemic in the Middle East, and both cutaneous and visceral forms are
reported from the region ranging from the Levant to Afghanistan. The potential and proven …